Ron Finklestien
Navigating the 21.2% Decline of First Solar: Investment Strategies Moving Forward
“`html First Solar Inc. (FSLR) has seen its shares decline by 21.2% over the past six months, underperforming the Zacks solar industry’s decline of ...
Paylocity (PCTY) Primed for Recovery After 10.2% Decline in 4 Weeks
Paylocity (PCTY) has experienced a 10.2% decline in stock value over the past four weeks, raising concerns about selling pressure. Currently, the stock has ...
Assessing the Value of SoundHound Stock: Is It Still a Good Investment?
SoundHound AI, Inc. (SOUN) reported a revenue of $29.1 million in Q1 2025, reflecting a 151% year-over-year growth. The company also activated over 1,000 ...
Comparing CRDO and MRVL: Which AI Connectivity Stock Offers Greater Potential?
Credo Technology Group Holding Ltd (CRDO) and Marvell Technology, Inc (MRVL) are semiconductor companies focused on high-speed connectivity solutions for AI-driven data centers. Both ...
The Trade Desk’s $386M Stock Buyback: Strategic Financial Decision?
“`html The Trade Desk, Inc. (TTD) reported a first-quarter 2025 cash outflow of $386 million for common stock buybacks. The firm generated $291 million ...
Should You Hold onto Prologis Stock in Your Portfolio?
“`html Prologis (PLD) is set to leverage its strategically located modern distribution facilities, expecting a year-over-year rental revenue increase of 6.3% in 2025. The ...
Comparing Growth Prospects: IBM vs. Oracle in the Hybrid Cloud Sector
IBM and Oracle are key players in the hybrid cloud infrastructure and database services sectors. IBM’s cloud services and solutions support enterprise digital transformation, ...
ASML Holding Sees 10% YTD Gain: Time to Consider Investing?
ASML Holding has achieved a year-to-date (YTD) gain of 10%, significantly outperforming the Zacks Computer and Technology sector’s rise of 1.5%. Notably, ASML’s performance ...
Potential Stock Surge for QIAGEN Following New QIAcuity dPCR IVD Partnership with GENCURIX
QIAGEN N.V. (QGEN) has partnered with South Korea-based GENCURIX, Inc. to develop oncology assays for the QIAcuityDx digital PCR platform. This collaboration marks GENCURIX ...
